Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Símbolo:
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
07/05/202406:32Edgar (US Regulatory)Form 8-K - Current reportNYSE:MLMoneyLion Inc
07/05/202406:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:HLNCFHaleon PLC (PK)
07/05/202406:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRRKScholar Rock Holdings Corporation
07/05/202406:30GlobeNewswire Inc.Caledonia Mining Corporation Plc: Results of Annual General MeetingAMEX:CMCLCaledonia Mining Corporation Plc
07/05/202406:30GlobeNewswire Inc.Crown Castle’s Highly Qualified Board of Directors is Driving Strategic Actions to Enhance ValueNYSE:CCICrown Castle Inc
07/05/202406:30Business WireOmni Design Technologies Named Winner of the TiE50 Award and TiE50 Showcase Judges Choice Award
07/05/202406:30GlobeNewswire Inc.Amesite Announces Strategic Five-Year Partnership with Franciscan Missionaries of Our Lady University to Deliver Healthcare Training for Healthcare ProfessionalsNASDAQ:AMSTAmesite Inc
07/05/202406:30Business WireSilver Storm Announces La Estrella Zone Drill ResultsTSXV:SVRSSilver Storm Mining Ltd
07/05/202406:30GlobeNewswire Inc.iSpecimen Reports First Quarter 2024 ResultsNASDAQ:ISPCiSpecimen Inc
07/05/202406:30GlobeNewswire Inc.Enable Injections Expands Strategic Partnership with Roche
07/05/202406:30GlobeNewswire Inc.Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ABEOAbeona Therapeutics Inc
07/05/202406:30GlobeNewswire Inc.Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA FeedbackNASDAQ:IVVDInvivyd Inc
07/05/202406:30GlobeNewswire Inc.Knight to Present at the 2024 RBC Capital Markets Global Healthcare Conference in New York CityTSX:GUDKnight Therapeutics Inc
07/05/202406:30GlobeNewswire Inc.Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesNASDAQ:PALIPalisade Bio Inc
07/05/202406:30GlobeNewswire Inc.Dave Reports Record First Quarter 2024 ResultsNASDAQ:DAVEDave Inc
07/05/202406:30GlobeNewswire Inc.Surgery Partners, Inc. Announces First Quarter 2024 ResultsNASDAQ:SGRYSurgery Partners Inc
07/05/202406:30Business WireInnovid Reports Q1 2024 Financial ResultsNYSE:CTVInnovid Corp
07/05/202406:30GlobeNewswire Inc.Calvetti Ferguson Supports Firm Growth in Nashville with New Business Development Officer and Tax Director
07/05/202406:30Business WireVerastem Oncology to Present at the RBC Capital Markets Global Healthcare ConferenceNASDAQ:VSTMVerastem Inc
07/05/202406:30Business WireComvest Credit Partners Provides $70 Million Senior Credit Facility to Nationwide Energy Partners to Support Growth Strategy
07/05/202406:30Business WireMoneyLion Announces First Quarter 2024 ResultsNYSE:MLMoneyLion Inc
07/05/202406:30GlobeNewswire Inc.Intra-Cellular Therapies Reports First Quarter 2024 Financial ResultsNASDAQ:ITCIIntra Cellular Therapies Inc
07/05/202406:30Business WireDelek Logistics Reports First Quarter 2024 ResultsNYSE:DKLDelek Logistics Partners LP
07/05/202406:30GlobeNewswire Inc.Altimmune to Participate at Two Upcoming Investor ConferencesNASDAQ:ALTAltimmune Inc
07/05/202406:30GlobeNewswire Inc.Lexeo Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:LXEOLexeo Therapeutics Inc
07/05/202406:30GlobeNewswire Inc.Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorderNASDAQ:IXHLIncannex Healthcare Ltd
07/05/202406:30GlobeNewswire Inc.Hillman Reports First Quarter 2024 ResultsNASDAQ:HLMNHillman Solutions Corporation
07/05/202406:30GlobeNewswire Inc.Neuronetics Reports Record First Quarter 2024 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
07/05/202406:30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming May Investor ConferencesNASDAQ:RGENRepligen Corp
07/05/202406:30GlobeNewswire Inc.Arbutus to Participate in Two Upcoming Investor ConferencesNASDAQ:ABUSArbutus Biopharma Corporation